BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20107735)

  • 1. Photoleukomelanoderma possibly caused by etretinate in a patient with psoriasis.
    Seishima M; Shibuya Y; Kato G; Watanabe K
    Acta Derm Venereol; 2010; 90(1):85-6. PubMed ID: 20107735
    [No Abstract]   [Full Text] [Related]  

  • 2. Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy.
    Yamamoto T; Watanabe K; Nishioka K
    Dermatology; 2004; 209(1):77. PubMed ID: 15237278
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombocytopenia possibly induced by etretinate in a psoriatic patient.
    Seishima M; Oda M; Yamanaka S
    J Dermatol; 2005 Nov; 32(11):917-20. PubMed ID: 16361755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acitretin induced bipedal edema.
    Tey HL; Theng TS
    J Dermatol; 2006 May; 33(5):372-4. PubMed ID: 16700673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphomatoid photocontact dermatitis to benzydamine hydrochloride.
    Alvarez-Garrido H; Sanz-Muñoz C; Martínez-García G; Miranda-Romero A
    Contact Dermatitis; 2010 Feb; 62(2):117-9. PubMed ID: 20136895
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteoporosis is a toxic effect of long-term etretinate therapy.
    DiGiovanna JJ; Sollitto RB; Abangan DL; Steinberg SM; Reynolds JC
    Arch Dermatol; 1995 Nov; 131(11):1263-7. PubMed ID: 7503569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatous nodule on vocal cord possibly induced by etretinate therapy.
    Kanoh H; Izumi T; Hiramatsu T; Ohnishi M; Murai M; Seishima M
    Br J Dermatol; 2000 Jun; 142(6):1258-60. PubMed ID: 10848772
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis verrucosa.
    Wakamatsu K; Naniwa K; Hagiya Y; Ichimiya M; Muto M
    J Dermatol; 2010 Dec; 37(12):1060-2. PubMed ID: 21083712
    [No Abstract]   [Full Text] [Related]  

  • 11. Case report: psoriatic erythroderma with bilateral osseous bridge across the acetabulum.
    Tsuji S; Tomita T; Inaoka M; Higashiyama M
    Clin Orthop Relat Res; 2010 Apr; 468(4):1173-7. PubMed ID: 19657703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic UVA exposure: protective effect on skin induced pigmentation by a daily use of a day care cream containing broad band sunscreen.
    Duteil I; Queille-Roussel C; Rougier A; Richard A; Ortonne JP
    Eur J Dermatol; 2002; 12(4):XVII-XVIII. PubMed ID: 12120614
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.
    Lam J; Polifka JE; Dohil MA
    J Am Acad Dermatol; 2008 Aug; 59(2):295-315. PubMed ID: 18410980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroderma in a patient taking acitretin for plaque psoriasis.
    Ahdout J; Mandel H; Chiu M
    J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports).
    Kokelj F; Plozzer C; Torsello P; Trevisan G
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate].
    Seishima M; Mori S; Seishima M; Noma A
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):731-4. PubMed ID: 2585775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
    Schopf RE; Hultsch T; Lotz J; Bräutigam M
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of PUVA-induced keratoses to etretinate.
    Hudson-Peacock MJ; Angus B; Farr PM
    J Am Acad Dermatol; 1996 Jul; 35(1):120-3. PubMed ID: 8682951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.